GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (CHIX:ARGXb) » Definitions » Market Cap

argenx SE (CHIX:ARGXB) Market Cap : €34,730 Mil (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). argenx SE's share price for the quarter that ended in Sep. 2024 was €481.8. argenx SE's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 60 Mil. Therefore, argenx SE's market cap for the quarter that ended in Sep. 2024 was €28,810 Mil.

argenx SE's quarterly market cap increased from Mar. 2024 (€21,746 Mil) to Jun. 2024 (€23,990 Mil) and increased from Jun. 2024 (€23,990 Mil) to Sep. 2024 (€28,810 Mil).

argenx SE's annual market cap increased from Dec. 2021 (€16,131 Mil) to Dec. 2022 (€19,322 Mil) and increased from Dec. 2022 (€19,322 Mil) to Dec. 2023 (€20,289 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. argenx SE's Enterprise Value for Today is €31,800 Mil.


argenx SE Market Cap Historical Data

The historical data trend for argenx SE's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Market Cap Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,166.21 11,512.25 16,130.84 19,322.09 20,288.91

argenx SE Quarterly Data
Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27,276.54 20,288.91 21,745.84 23,990.28 28,809.86

Competitive Comparison of argenx SE's Market Cap

For the Biotechnology subindustry, argenx SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Market Cap distribution charts can be found below:

* The bar in red indicates where argenx SE's Market Cap falls into.



argenx SE Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

argenx SE's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€342.75*59.1945
=€20,289

argenx SE's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=€481.8*59.7963
=€28,810

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE  (CHIX:ARGXb) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


argenx SE Market Cap Related Terms

Thank you for viewing the detailed overview of argenx SE's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

argenx SE Headlines

No Headlines